The Australian share market saw broad declines near noon (AEST) today, with most sectors trading lower amidst growing speculation about the Reserve Bank of Australia’s next move. National Australia Bank (NAB) notably tipped a September interest rate hike, reinforcing investor caution. This sentiment has kept the market on edge, as businesses and consumers brace for potential further tightening of monetary policy.
In corporate news, Ramsay Health Care bucked the trend, experiencing a significant rally after reporting a robust profit beat. Conversely, Qantas revealed a slide in profits, largely attributed to a $420 million hit from elevated fuel prices stemming from geopolitical tensions. Despite this, the airline anticipates revenue growth of between 8 and 10 per cent this year, driven by reduced seat capacity and higher airfares. Pharmacy giant Chemist Warehouse also posted substantial profit gains, buoyed by the burgeoning demand for weight-loss medications. The company plans to accelerate its global footprint, with new store openings slated for the United Kingdom.
Meanwhile, the financial sector saw Magellan, an Australian funds management company investing in global equities and other assets, post a record $778 million in revenue following its merger with Barrenjoey. Barrenjoey is a financial services firm providing investment banking, equities, and fixed income services. The merged entity, set to rebrand as Barrenjoey, is eyeing further expansion, including establishing operations in New Zealand. Separately, the collapse of developer Bathla has sent ripples through the private credit market, raising questions about lending practices. Filings indicate former Labor minister Frank Sartor assisted in calling in administrators, with La Trobe also noted for its exposure to the significant property giant’s failure.
